XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 164 filers reported holding XENON PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,571,120 | -11.6% | 192,363 | -0.3% | 0.02% | -8.0% |
| Q2 2023 | $7,431,848 | +9.1% | 193,035 | +1.4% | 0.02% | +8.7% |
| Q1 2023 | $6,813,700 | -9.4% | 190,380 | -0.2% | 0.02% | -14.8% |
| Q4 2022 | $7,523,007 | -45.7% | 190,794 | -50.3% | 0.03% | 0.0% |
| Q3 2022 | $13,850,280 | +19.0% | 383,672 | +0.3% | 0.03% | +22.7% |
| Q2 2022 | $11,641,897 | -2.4% | 382,702 | -1.9% | 0.02% | +29.4% |
| Q1 2022 | $11,925,740 | +95.7% | 390,104 | +100.0% | 0.02% | +6.2% |
| Q4 2021 | $6,093,000 | +149.8% | 195,048 | +22.2% | 0.02% | +128.6% |
| Q3 2021 | $2,439,000 | – | 159,643 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 790,000 | $12,071,000 | 3.53% |
| GREAT POINT PARTNERS LLC | 700,000 | $10,696,000 | 2.49% |
| COMMODORE CAPITAL LP | 579,432 | $8,854,000 | 2.33% |
| ACUTA CAPITAL PARTNERS, LLC | 417,409 | $6,378,000 | 2.25% |
| DAFNA Capital Management LLC | 406,535 | $6,212,000 | 1.65% |
| Tri Locum Partners LP | 264,134 | $4,036,000 | 1.60% |
| Parkman Healthcare Partners LLC | 311,207 | $4,755,000 | 1.20% |
| Ghost Tree Capital, LLC | 250,000 | $3,820,000 | 1.12% |
| Nan Fung Group Holdings Ltd | 197,880 | $3,024,000 | 0.97% |
| BVF INC/IL | 1,571,778 | $24,017,000 | 0.94% |